• Competing with precision: incentives for developing predictive biomarker tests 

      Brekke, Kurt Richard; Dalen, Dag Morten; Straume, Odd Rune (Journal article; Peer reviewed, 2023)
      We study the incentives of drug producers to develop predictive biomarkers, taking into account strategic interaction between drug producers and health plans. For this purpose, we develop a two-dimensional spatial framework ...
    • Paying for pharmaceuticals: uniform pricing versus two-part tariffs 

      Brekke, Kurt Richard; Dalen, Dag Morten; Straume, Odd Rune (Peer reviewed; Journal article, 2022)
      Two-part pricing (the Netflix model) has recently been proposed instead of uniform pricing for pharmaceuticals. Under two-part pricing the health plan pays a fixed fee for access to a drug at unit prices equal to marginal ...
    • The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets 

      Brekke, Kurt Richard; Dalen, Dag Morten; Straume, Odd Rune (Journal article; Peer reviewed, 2023)
      Health systems around world are increasingly adopting cost-effectiveness (CE) analysis to inform decisions about access and reimbursement. We study how CE thresholds imposed by a health plan for granting reimbursement ...